Literature DB >> 18754678

The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling.

Patrick R Cushing1, Abigail Fellows, Daniel Villone, Prisca Boisguérin, Dean R Madden.   

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is an epithelial chloride channel mutated in patients with cystic fibrosis. Its expression and functional interactions in the apical membrane are regulated by several PDZ (PSD-95, discs large, zonula occludens-1) proteins, which mediate protein-protein interactions, typically by binding C-terminal recognition motifs. In particular, the CFTR-associated ligand (CAL) limits cell-surface levels of the most common disease-associated mutant DeltaF508-CFTR. CAL also mediates degradation of wild-type CFTR, targeting it to lysosomes following endocytosis. Nevertheless, wild-type CFTR survives numerous cycles of uptake and recycling. In doing so, how does it repeatedly avoid CAL-mediated degradation? One mechanism may involve competition between CAL and other PDZ proteins including Na (+)/H (+) exchanger-3 regulatory factors 1 and 2 (NHERF1 and NHERF2), which functionally stabilize cell-surface CFTR. Thus, to understand the biochemical basis of WT-CFTR persistence, we need to know the relative affinities of these partners. However, no quantitative binding data are available for CAL or the individual NHERF2 PDZ domains, and published estimates for the NHERF1 PDZ domains conflict. Here we demonstrate that the affinity of the CAL PDZ domain for the CFTR C-terminus is much weaker than those of NHERF1 and NHERF2 domains, enabling wild-type CFTR to avoid premature entrapment in the lysosomal pathway. At the same time, CAL's affinity is evidently sufficient to capture and degrade more rapidly cycling mutants, such as DeltaF508-CFTR. The relatively weak affinity of the CAL:CFTR interaction may provide a pharmacological window for stabilizing rescued DeltaF508-CFTR in patients with cystic fibrosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18754678      PMCID: PMC2582146          DOI: 10.1021/bi8003928

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  54 in total

1.  Modulation of mature cystic fibrosis transmembrane regulator protein by the PDZ domain protein CAL.

Authors:  Jie Cheng; Hua Wang; William B Guggino
Journal:  J Biol Chem       Date:  2003-10-21       Impact factor: 5.157

2.  The PDZ-binding chloride channel ClC-3B localizes to the Golgi and associates with cystic fibrosis transmembrane conductance regulator-interacting PDZ proteins.

Authors:  Martina Gentzsch; Liying Cui; April Mengos; Xiu-Bao Chang; Jey-Hsin Chen; John R Riordan
Journal:  J Biol Chem       Date:  2002-12-05       Impact factor: 5.157

3.  A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor.

Authors:  T T Cao; H W Deacon; D Reczek; A Bretscher; M von Zastrow
Journal:  Nature       Date:  1999-09-16       Impact factor: 49.962

4.  PDZ domain interaction controls the endocytic recycling of the cystic fibrosis transmembrane conductance regulator.

Authors:  Agnieszka Swiatecka-Urban; Marc Duhaime; Bonita Coutermarsh; Katherine H Karlson; James Collawn; Michal Milewski; Garry R Cutting; William B Guggino; George Langford; Bruce A Stanton
Journal:  J Biol Chem       Date:  2002-08-07       Impact factor: 5.157

5.  Interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL) inhibits beta1-adrenergic receptor surface expression.

Authors:  Junqi He; Michele Bellini; Jianguo Xu; Amanda M Castleberry; Randy A Hall
Journal:  J Biol Chem       Date:  2004-09-09       Impact factor: 5.157

6.  Peptide binding consensus of the NHE-RF-PDZ1 domain matches the C-terminal sequence of cystic fibrosis transmembrane conductance regulator (CFTR).

Authors:  S Wang; R W Raab; P J Schatz; W B Guggino; M Li
Journal:  FEBS Lett       Date:  1998-05-01       Impact factor: 4.124

Review 7.  Pharmacological approaches to correcting the ion transport defect in cystic fibrosis.

Authors:  Godfried M Roomans
Journal:  Am J Respir Med       Date:  2003

8.  A C-terminal motif found in the beta2-adrenergic receptor, P2Y1 receptor and cystic fibrosis transmembrane conductance regulator determines binding to the Na+/H+ exchanger regulatory factor family of PDZ proteins.

Authors:  R A Hall; L S Ostedgaard; R T Premont; J T Blitzer; N Rahman; M J Welsh; R J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

9.  An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cytoskeleton.

Authors:  D B Short; K W Trotter; D Reczek; S M Kreda; A Bretscher; R C Boucher; M J Stutts; S L Milgram
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

10.  Misfolding diverts CFTR from recycling to degradation: quality control at early endosomes.

Authors:  Manu Sharma; Francesca Pampinella; Csilla Nemes; Mohamed Benharouga; Jeffrey So; Kai Du; Kristi G Bache; Blake Papsin; Noa Zerangue; Harald Stenmark; Gergely L Lukacs
Journal:  J Cell Biol       Date:  2004-03-08       Impact factor: 10.539

View more
  63 in total

Review 1.  CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners.

Authors:  Chunying Li; Anjaparavanda P Naren
Journal:  Integr Biol (Camb)       Date:  2010-03-05       Impact factor: 2.192

Review 2.  Emerging Themes in PDZ Domain Signaling: Structure, Function, and Inhibition.

Authors:  Xu Liu; Ernesto J Fuentes
Journal:  Int Rev Cell Mol Biol       Date:  2018-06-28       Impact factor: 6.813

3.  Stereochemical preferences modulate affinity and selectivity among five PDZ domains that bind CFTR: comparative structural and sequence analyses.

Authors:  Jeanine F Amacher; Patrick R Cushing; Lionel Brooks; Prisca Boisguerin; Dean R Madden
Journal:  Structure       Date:  2013-11-07       Impact factor: 5.006

Review 4.  From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking.

Authors:  Carlos M Farinha; Sara Canato
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

5.  Ligand-induced dynamic changes in extended PDZ domains from NHERF1.

Authors:  Shibani Bhattacharya; Jeong Ho Ju; Natalia Orlova; Jahan Ali Khajeh; David Cowburn; Zimei Bu
Journal:  J Mol Biol       Date:  2013-04-10       Impact factor: 5.469

6.  Stereochemical determinants of C-terminal specificity in PDZ peptide-binding domains: a novel contribution of the carboxylate-binding loop.

Authors:  Jeanine F Amacher; Patrick R Cushing; Christopher D Bahl; Tobias Beck; Dean R Madden
Journal:  J Biol Chem       Date:  2012-12-15       Impact factor: 5.157

7.  Autoinhibitory interactions between the PDZ2 and C-terminal domains in the scaffolding protein NHERF1.

Authors:  Hong Cheng; Jianquan Li; Ruzaliya Fazlieva; Zhongping Dai; Zimei Bu; Heinrich Roder
Journal:  Structure       Date:  2009-05-13       Impact factor: 5.006

8.  PDZ domains and their binding partners: structure, specificity, and modification.

Authors:  Ho-Jin Lee; Jie J Zheng
Journal:  Cell Commun Signal       Date:  2010-05-28       Impact factor: 5.712

9.  Isoform-specific regulation and localization of the coxsackie and adenovirus receptor in human airway epithelia.

Authors:  Katherine J D A Excoffon; Nicholas D Gansemer; Matthew E Mobily; Philip H Karp; Kalpaj R Parekh; Joseph Zabner
Journal:  PLoS One       Date:  2010-03-26       Impact factor: 3.240

10.  SNX27 mediates PDZ-directed sorting from endosomes to the plasma membrane.

Authors:  Benjamin E L Lauffer; Cristina Melero; Paul Temkin; Cai Lei; Wanjin Hong; Tanja Kortemme; Mark von Zastrow
Journal:  J Cell Biol       Date:  2010-08-23       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.